FMT for Remission of Active Ulcerative Colitis in Adults

Inclusion Criteria: * Able to provide informed consent. * Willing and able to comply with all the required trial procedures * Active ulcerative colitis as defined by Mayo score \> 3 AND Mayo endoscopic sub-score \> 1 (within 30 days before enrollment, or at baseline) Exclusion Criteria: * Planned or actively taking another investigational product * Abdominal surgery within the past 60 days * Patients with neutropenia with absolute neutrophil count \<0.5 x 109/L at - Evidence of toxic megacolon or gastrointestinal perforation on imaging * Peripheral white blood cell count \> 35.0 x 109/L at enrollment AND temperature \> 38.0oC * Active infectious diarrhea at the time of enrolment * Increase in medical therapy for UC within 3 months of enrollment. Continued treatment with stable dose of 5-ASA, azathioprine, 6-mercaptopurine, cyclosporine, prednisone and/or anti- TNF agents for at least 3 months of is allowed * Severe UC requiring hospitalization at the time of enrolment * Pregnant or lactating * History of anaphylaxis to any food * Requiring oral and/or intravenous systemic antibiotic therapy at the time of study enrolment * Unwilling to discontinue probiotic (yogurt is allowed) * Severe underlying disease such that the patient is not expected to survive for at least 30 days. * Any condition that in the opinion of the investigator that would pose harm to the participant or the research staff for the potential participant to take part in the trial